相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate
Yun Ji et al.
NATURE COMMUNICATIONS (2019)
Updateon the current revolution in cancer immunotherapy
Ariana Nicole Renrick et al.
IMMUNOTHERAPY (2019)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function
Samuel T. Pellom et al.
ONCOTARGET (2017)
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade
Thomas B. Huffaker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The Transcription Factor T-Bet Is Regulated by MicroRNA-155 in Murine Anti-Viral CD8+T Cells via SHIP-1
Jennifer L. Hope et al.
FRONTIERS IN IMMUNOLOGY (2017)
The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection
Howell F. Moffett et al.
NATURE IMMUNOLOGY (2017)
MicroRNAs in Cancer: Challenges and Opportunities in Early Detection, Disease Monitoring, and Therapeutic Agents
Namita Chatterjee et al.
CURRENT PATHOBIOLOGY REPORTS (2017)
Genetic and Epigenetic Regulation of PD-1 Expression
Alexander P. R. Bally et al.
JOURNAL OF IMMUNOLOGY (2016)
MicroRNAs as regulatory elements in immune system logic
Arnav Mehta et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity
Anil Shanker et al.
CANCER RESEARCH (2015)
microRNAs function in CD8+T cell biology
Yan Liang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Bortezomib enhances expression of effector molecules in antitumor CD8+ T lymphocytes by promoting Notch-nuclear factor.B crosstalk
Menaka C. Thounaojam et al.
ONCOTARGET (2015)
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli et al.
THERANOSTICS (2015)
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokines
Yun Ji et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
MicroRNAs in Heart Failure Is the Picture Becoming Less miRky?
Yonathan F. Melman et al.
CIRCULATION-HEART FAILURE (2014)
Mir-155, a central modulator of T-cell responses
Evan F. Lind et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Critical Role of MicroRNA-155 in Herpes Simplex Encephalitis
Siddheshvar Bhela et al.
JOURNAL OF IMMUNOLOGY (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Progress and challenge of microRNA research in immunity
Hyang-Mi Lee et al.
FRONTIERS IN GENETICS (2014)
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
Giulia Nizzoli et al.
BLOOD (2013)
MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
Jan C. Dudda et al.
IMMUNITY (2013)
IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity
Beatriz M. Carreno et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire
Yelena Bronevetsky et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling
Donald T. Gracias et al.
NATURE IMMUNOLOGY (2013)
Role of inositol poly-phosphatases and their targets in T cell biology
Neetu Srivastava et al.
FRONTIERS IN IMMUNOLOGY (2013)
T-bet: a bridge between innate and adaptive immunity
Vanja Lazarevic et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation
Tuoqi Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Epistasis between MicroRNAs 155 and 146a during T Cell-Mediated Antitumor Immunity
Thomas B. Huffaker et al.
CELL REPORTS (2012)
Regulation and function of mTOR signalling in T cell fate decisions
Hongbo Chi
NATURE REVIEWS IMMUNOLOGY (2012)
miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1
Changming Lu et al.
BLOOD (2011)
Suppressor of cytokine signaling 1 (SOCS1) limits NFκB signaling by decreasing p65 stability within the cell nucleus
Julia Strebovsky et al.
FASEB JOURNAL (2011)
Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression
Carlos H. Serezani et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
Fabian Sievers et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection
Charlly Kao et al.
NATURE IMMUNOLOGY (2011)
RNAstructure: software for RNA secondary structure prediction and analysis
Jessica S. Reuter et al.
BMC BIOINFORMATICS (2010)
Regulation of MicroRNA Expression and Abundance during Lymphopoiesis
Stefan Kuchen et al.
IMMUNITY (2010)
Absence of SHIP-1 Results in Constitutive Phosphorylation of Tank-Binding Kinase 1 and Enhanced TLR3-Dependent IFN-β Production
Joan Ni Gabhann et al.
JOURNAL OF IMMUNOLOGY (2010)
Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex
Alan D. Brooks et al.
MOLECULAR CANCER RESEARCH (2010)
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naive patients with advanced stage non-small cell lung cancer (NSCLC)
Tianhong Li et al.
LUNG CANCER (2010)
Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2010)
The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs
Ariadne Androulidaki et al.
IMMUNITY (2009)
Inositol phosphatase SHIP1 is a primary target of miR-155
Ryan M. O'Connell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function
Douglas C. Palmer et al.
TRENDS IN IMMUNOLOGY (2009)
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma - A phase 2 trial of the Minnie Pearl Cancer Research Network
John D. Hainsworth et al.
CANCER (2008)
Targeted deletion reveals essential and overlapping functions of the miR-17∼92 family of miRNA clusters
Andrea Ventura et al.
CELL (2008)
Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody
Anil Shanker et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells
Elena Vigorito et al.
IMMUNITY (2007)
Bortezomib for the treatment of mantle cell lymphoma
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2007)
T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses
Tatyana Tarasenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation
Laura Fontana et al.
NATURE CELL BIOLOGY (2007)
Regulation of the germinal center response by microRNA-155
To-Ha Thai et al.
SCIENCE (2007)
MicroRNA-155 is induced during the macrophage inflammatory response
Ryan M. O'Connell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
FcγR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways
Latha P. Ganesan et al.
BLOOD (2006)
RNAhybrid:: microRNA target prediction easy, fast and flexible
Jan Krueger et al.
NUCLEIC ACIDS RESEARCH (2006)
United States Food and Drug Administration approval summary: Bortezomib for the treatment of progressive multiple myeloma after one prior therapy
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2006)
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma
OA O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MicroRNAs modulate hematopoietic lineage differentiation
CZ Chen et al.
SCIENCE (2004)
Approval summary for bortezomib for injection in the treatment of multiple myeloma
PF Bross et al.
CLINICAL CANCER RESEARCH (2004)
Fast and effective prediction of microRNA/target duplexes
M Rehmsmeier et al.
RNA (2004)
SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide
LM Sly et al.
EXPERIMENTAL HEMATOLOGY (2003)
分享论文
